(Q27852608)

13 November 2016

title

Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer (English)

1 reference

PubMed

PubMed publication ID

13 November 2016

1 reference

1 reference

3

Suzanne Kamel-Reid

0 references

Ming-Sound Tsao

Ming Tsao

4

0 references

Blaise A Clarke

Blaise Clarke

5

0 references

Lars A. Akslen

9

Lars A Akslen

0 references

Jone Trovik

8

Jone Trovik

0 references

Amit M. Oza

Amit M Oza

12

1 reference

ORCID Public Data File 2021

Helga Salvesen

10

Helga B Salvesen

0 references

Henrica M J Werner

7

Henrica M J Werner

0 references

author name string

Helen J Mackay

1

0 references

Elizabeth A Eisenhauer

2

0 references

Katherine Karakasis

6

0 references

Dongsheng Tu

Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group

11

0 references

language of work or name

English

0 references

publication date

15 February 2014

0 references

published in

Cancer

0 references

volume

120

0 references

issue

4

0 references

page(s)

603-10

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers--a study of the National Cancer Institute of Canada Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Metformin in cancer: translational challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin/Op18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

7 January 2021

Hormonal treatment of endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

7 January 2021

Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

7 January 2021

Treatment of Advanced Endometrial Carcinoma with Tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

7 January 2021

PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

7 January 2021

Use of mutation profiles to refine the classification of endometrial carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

7 January 2021

Evolution in Endometrial Cancer: Evidence From an Immunohistochemical Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28414

7 January 2021

Identifiers

DOI

10.1002/CNCR.28414

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24166148

1 reference

Consolidated OpenCitations Corpus – April 2017